Search

everythinglearnresearchcommunity

for

Search:↓

Different hormones affect hair growth and conditions, with some causing hair loss and others promoting it.

Frontal fibrosing alopecia is a poorly understood condition with increasing cases and unclear treatment effectiveness.

Telogen Effluvium is a common hair loss condition, particularly in women, with no specific FDA-approved treatment, and recovery can take up to 18 months.

Scalp biopsies are important for diagnosing hair loss conditions.

Frontal fibrosing alopecia is a complex condition with no definitive treatment.

A woman's rare hair loss condition improved on its own, suggesting this type might recover like common cases.

PCOS is a common and costly condition in North American women, causing various health issues like obesity, diabetes, and fertility problems.

Telogen effluvium is a hair loss condition that can be treated with medications like minoxidil.

Alopecia Areata is an unpredictable autoimmune hair loss condition with limited and variable treatment effectiveness.

Different hair and nail conditions can indicate health issues and have specific treatments; accurate diagnosis is crucial before treatment.

Physical symptoms in depression can reveal underlying medical conditions.

An 11-year-old girl's hair regrew after treating her thyroid condition with carbimazole.

The patient with autoimmune hypothyroidism improved after treatment for thyroid and associated conditions.

Patients with Frontal fibrosing alopecia in Morocco often have skin conditions and thyroid disorders.

Every elderly patient had at least one skin condition, often linked to other diseases, highlighting the need for integrated skin and general healthcare in the elderly.

Hormone imbalances from endocrine diseases can cause various skin conditions that help diagnose and treat these diseases early.

Alopecia Areata often runs in families and is linked to other autoimmune conditions.

Immunotherapy for cancer caused a patient to develop a condition affecting hormone production, requiring ongoing hormone replacement therapy.

A woman with severe hypothyroidism had a rare skin condition usually linked to a different thyroid disease.

Alopecia areata is a hair loss condition that often starts before age 30 and can affect various body parts, with unpredictable hair regrowth chances.

Vitiligo is often linked with thyroid disease and other autoimmune conditions.

People with Lichen sclerosus are more likely to have skin conditions like vitiligo and alopecia areata, heart disease risks, and other health issues. They should be checked for these, but screening plans shouldn't differ based on gender due to lack of data.

The expert system effectively helps diagnose and treat hair loss conditions.

People with alopecia areata are more likely to have thyroid autoimmunity, but not thyroid disease.

Contact immunotherapy can cause vitiligo in patients with autoimmune conditions.

Hormones significantly influence hair growth, with conditions like hirsutism and patterned hair loss linked to hormone levels; more research is needed for full understanding.

Thyroid problems can cause hair loss and change hair texture.

Most patients with frontal fibrosing alopecia are middle-aged women, often have thyroid disease, and some treatments can help stabilize the condition.

Alopecia areata patients often have undetected thyroid issues, so routine thyroid screening is recommended.

Doctors in the Middle East need better treatments and more knowledge about new therapies for hair loss condition Alopecia Areata.